Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. September 2016 10:00 ET | Quelle: Rejuvatek Medical

Tatt2Away Revolutionizes Tattoo Removal in Canada

MONTREAL, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Until recently, tattoo removal had not seen a significant advancement in treatment, technique or outcomes in years. Marie Lariault, owner of Les...
26. September 2016 09:59 ET | Quelle: NJ Hall of Fame

New Jersey Hall of Fame and New Jersey Education Association Renew Scholarships Challenging Students to Realize Their Best

TRENTON, N.J., Sept. 26, 2016 (GLOBE NEWSWIRE) -- The New Jersey Hall of Fame (NJHOF) together with the New Jersey Education Association (NJEA) announces the renewal of the “Arête Scholarship” which...
26. September 2016 09:00 ET | Quelle: Pentaho, a Hitachi Data Systems company

Five new Pentaho data integration enhancements, including SQL on Spark, deliver value faster and future proof big data projects

NEW YORK, Sept. 26, 2016 (GLOBE NEWSWIRE) -- (Strata + Hadoop World, Booth #533) -- Pentaho, a Hitachi Group Company, today announced five new improvements, including SQL on Spark, to help...
26. September 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Awarded Grant from U.S. Department of Agriculture to Develop Point-of-Care Diagnostic Test for Bovine Tuberculosis

MEDFORD, N.Y., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that the...
26. September 2016 08:30 ET | Quelle: Minerva Neurosciences, Inc.

Minerva Neurosciences Provides Update on MIN-101 and MIN-117 Clinical Programs

Last patient completes extension phase of Phase IIb trial with MIN-101 Company receives FDA acceptance of Investigational New Drug Application for MIN-117 WALTHAM, Mass., Sept. 26, 2016 (GLOBE...
26. September 2016 08:00 ET | Quelle: Fate Therapeutics, Inc.

Fate Therapeutics Receives FDA Orphan Drug Designation for ProTmune™ in Allogeneic Hematopoietic Cell Transplantation

SAN DIEGO, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...
26. September 2016 08:00 ET | Quelle: Innara Health

NTrainer System named Innovative Technology by Vizient

ContactWendy SlateryFOR IMMEDIATE RELEASETelephone913-742-4456Sept. 26, 2016E-mailwslatery@innarahealth.com Olathe, Kan., Sept. 26, 2016 (GLOBE NEWSWIRE) -- The NTrainer System by Innara...
26. September 2016 08:00 ET | Quelle: Aduro Biotech, Inc.

Aduro Biotech’s Stephen T. Isaacs Named 2016 Visionary Leader by Berkeley Chamber of Commerce

BERKELEY, Calif., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that Stephen T. Isaacs, the company’s chairman, president and CEO, will receive the Berkeley...
26. September 2016 08:00 ET | Quelle: Qorvo, Inc.

Qorvo® Adds Control Products to Industry’s Most Comprehensive CATV Portfolio

GREENSBORO, N.C., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced the expansion of its CATV product...
26. September 2016 05:25 ET | Quelle: Bell Integrator

Bell Integrator Develops Product for OSS domain

SAN JOSE, Calif., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Bell Integrator, a global consulting, technology services and outsourcing company, has announced today that it has developed an out-of-the-box...

Vorherige Seite

Nächste Seite